Skip to main navigation Skip to search Skip to main content

Ovine Pulmonary Adenocarcinoma: A large animal model for human lung cancer

  • Gehad Youssef
  • , William Wallace
  • , Mark P Dagleish
  • , Chris Cousens
  • , David J Griffiths

Research output: Contribution to journalArticlepeer-review

Abstract

Lung cancer is the leading cause of cancer deaths worldwide. Recent progress in understanding the molecular pathogenesis of this disease has resulted in novel therapeutic strategies targeting specific groups of patients. Further studies are required to provide additional advances in diagnosis and treatment. Animal models are valuable tools for studying oncogenesis in lung cancer, particularly during the early stages of disease where tissues are rarely available from human cases. Mice have traditionally been used for studying lung cancer in vivo, and a variety of spontaneous and transgenic models are available. However, it is recognized that other species may also be informative for studies of cancer. Ovine pulmonary adenocarcinoma (OPA) is a naturally occurring lung cancer of sheep caused by retrovirus infection and has several features in common with adenocarcinoma of humans, including a similar histological appearance and activation of common cell signaling pathways. Additionally, the size and organization of human lungs are much closer to those of sheep lungs than to those of mice, which facilitates experimental approaches in sheep that are not available in mice. Thus OPA presents opportunities for studying lung tumor development that can complement conventional murine models. Here we describe the potential applications of OPA as a model for human lung adenocarcinoma with an emphasis on the various in vivo and in vitro experimental systems available.
Original languageEnglish
Pages (from-to)99-115
Number of pages17
JournalILAR Journal
Volume56
Issue number1
DOIs
Publication statusPublished - 19 May 2015

Fingerprint

Dive into the research topics of 'Ovine Pulmonary Adenocarcinoma: A large animal model for human lung cancer'. Together they form a unique fingerprint.

Cite this